Status:
RECRUITING
Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Stroke, Ischemic
Eligibility:
All Genders
20+ years
Brief Summary
Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke is a multi-centers registration. It starts in Jan 2019. The key items in the registration form include basic demographic profiles...
Detailed Description
Stroke is the second leading cause of death and third leading cause of disability worldwide. Until recently, intravenous recombinant tissue-type plasminogen activator (r-tPA) was the only therapy that...
Eligibility Criteria
Inclusion
- Acute ischemic stroke caused by intracranial large vessel occlusion
- Can be treated within 24 hours of stroke onset.
- Large vessel occlusion demonstrated by magnetic resonance imaging angiography (MRA), computed tomography angiography (CTA) or digital substraction angiography (DSA).
- Pre-stroke independence (modified Rankin Scale 0-2).
Exclusion
- Other cause of stroke, such as intracranial hemorrhage.
- Not underwent endovascular thrombectomy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05281055
Start Date
January 1 2019
End Date
December 31 2030
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100